ginkgolide c has been researched along with Colitis Gravis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, J; Fu, S; Gao, S; Hu, G; Liu, D; Liu, J; Ma, H; Xu, D; Zhuang, L | 1 |
1 other study(ies) available for ginkgolide c and Colitis Gravis
Article | Year |
---|---|
Orally Administered Ginkgolide C Attenuates DSS-Induced Colitis by Maintaining Gut Barrier Integrity, Inhibiting Inflammatory Responses, and Regulating Intestinal Flora.
Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Humans; Lactones; Mice; Mice, Inbred C57BL; NF-kappa B; Tight Junction Proteins | 2022 |